The FDA evaluates nominated substances using a balancing test that considers physical and chemical characterization, safety issues, available evidence of effectiveness or lack of effectiveness, and historical use in compounding
Recent animal research in 2025 explored its role in colitis, showing mucosal healing and reduced inflammation
Research shows that increased NNMT is strongly associated with obesity, so targeting this enzyme could be beneficial for weight loss [2]
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component peptide, or the blend formulation, as a drug for human or veterinary use
Together, let's raise critical funds to drive progress toward curing psoriatic disease and improving the lives of those affected